✦ LIBER ✦

Comparison of protein kinase C activity and isoform expression in cisplatin-sensitive and -resistant ovarian carcinoma cells

✍ Scribed by Alakananda Basu; Kelly M. Weixel

Publisher: John Wiley and Sons
Year: 1995
Tongue: French
Weight: 514 KB
Volume: 62
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.2910620416

No coin nor oath required. For personal study only.

✦ Synopsis

Cellular sensitivity to cis-diamminedichloroplatinum(ll) (cDDP) can be regulated by protein kinase C (PKC) signal transduction pathway. Activators of PKC were shown to enhance the sensitivity of human ovarian carcinoma 2008 cells to cDDP. We have examined whether or not the PKC signal transduction pathway is affected during development of resistance by tumor cells to cDDP. A 2-fold decrease in PKC activity was observed in cDDP-resistant ovarian carcinoma 2008/ C 13.5.25 cells compared with the drug-sensitive 2008 cells. Subcellular distribution studies revealed a reduction in both cytosolic and particulate PKC activities in 2008/CI 3.5.25 cells. The pattern of PKC isoform expression was compared in cDDP-sensitive and -resistant cell lines by Western blot analysis with isoform-specific antibodies to PKC. The parental cells expressed PKCa, -c, and -6 isoforms. The abundance of PKCo: decreased significantly in 2008/C I3*5.25 cells, whereas the amount of PKCe increased moderately in the resistant variant, with no alteration in PKC< content. Therefore, a reduction in PKCa and/or an increase in PKCc expression may be associated with the drug-resistant phenotype.

📜 SIMILAR VOLUMES

Cisplatin-induced response of c-jun N-te

Cisplatin-induced response of c-jun N-terminal kinase 1 and extracellular signal-regulated protein kinases 1 and 2 in a series of cisplatin-resistant ovarian carcinoma cell lines

✍ Wei Cui; Eugenia M. Yazlovitskaya; Matthew S. Mayo; Jill C. Pelling; Diane L. Pe 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 2 views

Hyperphosphorylation of replication prot

Hyperphosphorylation of replication protein A in cisplatin-resistant and -sensitive head and neck squamous cell carcinoma cell lines

✍ Karoline C. Manthey; Jason G. Glanzer; Diana D. Dimitrova; Greg G. Oakley 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 3 views

## Abstract ## Background Resistance to chemotherapy is a major limitation in the treatment of head and neck squamous cell carcinomas (HNSCCs), accounting for high mortality rates in patients. Here, we investigated the role of replication protein A (RPA) in cisplatin and etoposide resistance. ##

PROTEIN KINASE C IN ERYTHROLEUKAEMIA CEL

PROTEIN KINASE C IN ERYTHROLEUKAEMIA CELLS: TEMPORAL VARIATIONS IN THE EXPRESSION OF THE ALPHA, EPSILON AND ZETA ISOFORMS

✍ K.D. Hammond; N. Savage; M. Littlewood 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Determinations of mRNA and enzyme protein analyses for the protein kinase C (PKC) isoforms, alpha, epsilon and zeta, representing the classical, novel and atypical groups, respectively, in murine erythroleukaemic (MEL) cells revealed the occurrence of cyclic behaviour in expression. Such rhythmicity

Retinoic acid induced growth arrest of h

Retinoic acid induced growth arrest of human breast carcinoma cells requires protein kinase Cα expression and activity

✍ Yunhi Cho; Ann P. Tighe; David A. Talmage 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB 👁 1 views

Retinoic acid inhibits proliferation of hormone-dependent, but not hormone-independent breast cancer cells. Retinoic acid-induced changes in cellular proliferation and differentiation are associated with disturbances in growth factor signaling and frequently with changes in protein kinase C expressi

Long-term activation of SAPK/JNK, p38 ki

Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance

✍ Anamaria Brozovic; Gerhard Fritz; Markus Christmann; Jochen Zisowsky; Ulrich Jae 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 822 KB

## Abstract Tumor cells chronically exposed to cisplatin (cDDP) acquire cDDP resistance that impacts tumor therapy. To elucidate the mechanism of acquired cDDP resistance (ACR), we compared HeLa cells that gained ACR upon chronic cDDP treatment with the parental strain. We show that ACR is due to a

Expression of protein kinase C β1 confer

Expression of protein kinase C β1 confers resistance to TNFα- and paclitaxel-induced apoptosis in HT-29 colon carcinoma cells

✍ Patrizia Cesaro; Elisabetta Raiteri; Marina Démoz; Roberta Castino; Francesco M. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 173 KB

The expression of different protein kinase C (PKC) isoenzymes has been shown to vary with proliferation rates, differentiation or apoptosis in normal colon crypts. In addition, the activity of some PKC isoenzymes appears to be reduced in colorectal cancer. The aim of the present work was to determin